Nonprofit Innovation The Melanoma Institute Australia (MIA) is a non-profit focused on zero deaths from melanoma through world-class research, treatment, and education, affiliated with The University of Sydney and St Vincent’s and Mater Health Sydney, indicating potential for partnerships, grants, and research collaborations.

Strategic Partnerships MIA operates from the Poche Centre, the world’s largest melanoma research and treatment centre, signaling collaboration opportunities with leading academic and clinical institutions, as well as potential sponsorships or joint programs.

Global Research Presence Active participation in major conferences (AACR, EADO, ASCO) and frequent dissemination of findings suggests demand for research services, data partnerships, sponsored studies, and knowledge transfer opportunities.

National Screening Initiative MIA is leading a Roadmap for a National Targeted Skin Cancer Screening Program, indicating potential for scalable program design, digital health solutions, data analytics, and early-detection technology collaborations.

Funding & Growth With revenue in the $1M–$10M range and a relatively lean team (51–200 employees), there is appetite for scalable technology platforms, grant management, donor engagement solutions, and outsourced research administration services to support growth.